Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer.
暂无分享,去创建一个
[1] M. Textor,et al. Dimensionality Controls Cytoskeleton Assembly and Metabolism of Fibroblast Cells in Response to Rigidity and Shape , 2010, PloS one.
[2] K O Greulich,et al. UVA-induced apoptosis studied by the new apo/necro-Comet-assay which distinguishes viable, apoptotic and necrotic cells. , 2006, Mutagenesis.
[3] D. Henley,et al. Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity , 2006, Cancer Chemotherapy and Pharmacology.
[4] C. Mettlin,et al. Global breast cancer mortality statistics , 1999, CA: a cancer journal for clinicians.
[5] G. Adler,et al. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. , 2006, Cancer research.
[6] Rolf Larsson,et al. Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828. , 2004, Molecular cancer therapeutics.
[7] Alok R Ray,et al. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. , 2005, Biomaterials.
[8] E. Cukierman,et al. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins , 2009, BMC Cancer.
[9] Dietmar W Hutmacher,et al. The challenge to measure cell proliferation in two and three dimensions. , 2005, Tissue engineering.
[10] J. Heino. The collagen receptor integrins have distinct ligand recognition and signaling functions. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[11] Juergen Friedrich,et al. Experimental anti-tumor therapy in 3-D: Spheroids – old hat or new challenge? , 2007, International journal of radiation biology.
[12] P. Janmey,et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. , 2005, Cell motility and the cytoskeleton.
[13] E. Kubista,et al. Extracellular matrix proteins influence phenotype and cytokine expression in human breast cancer cell lines. , 2002, European cytokine network.
[14] J. Bryant,et al. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Christopher S. Chen,et al. Cellular and multicellular form and function. , 2007, Advanced drug delivery reviews.
[16] J. van den Dolder,et al. The behavior of osteoblast-like cells on various substrates with functional blocking of integrin-β1 and integrin-β3 , 2007, Journal of materials science. Materials in medicine.
[17] W. Dalton,et al. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death , 2003, Oncogene.
[18] Kenneth M. Yamada,et al. Cell migration in 3D matrix. , 2005, Current opinion in cell biology.
[19] L. Kam,et al. Rigidity-dependent cross talk between integrin and cadherin signaling. , 2009, Biophysical journal.
[20] E. Golemis,et al. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. , 2008, Matrix biology : journal of the International Society for Matrix Biology.
[21] Dan H. Moore,et al. Increased β1 Integrin Is Associated with Decreased Survival in Invasive Breast Cancer , 2007 .
[22] F. Aoudjit,et al. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells , 2001, Oncogene.
[23] S. Sahoo,et al. 3-D tumor model for in vitro evaluation of anticancer drugs. , 2008, Molecular pharmaceutics.
[24] Tobias Schmelzle,et al. Engineering tumors with 3D scaffolds , 2007, Nature Methods.
[25] Jie Liu,et al. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. , 2009, Toxicology and applied pharmacology.
[26] A. Ivascu,et al. Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis , 2006, Journal of biomolecular screening.
[27] Robert S. Kerbel,et al. E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.
[28] M. Textor,et al. single cells{ , 2007 .
[29] Viola Vogel,et al. Crosslinking of cell-derived 3D scaffolds up-regulates the stretching and unfolding of new extracellular matrix assembled by reseeded cells. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[30] Genee Y. Lee,et al. The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.
[31] T. Aas,et al. Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy. , 2003, European journal of cancer.
[32] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[33] G. Hortobagyi,et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. , 1991, Journal of the National Cancer Institute.
[34] Christopher S. Chen,et al. Engineering cellular microenvironments to improve cell-based drug testing. , 2002, Drug discovery today.
[35] A. Charchanti,et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. , 2002, European journal of cancer.
[36] Robert A. Gatenby,et al. Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.
[37] G. Hortobagyi. Opportunities and challenges in the development of targeted therapies. , 2004, Seminars in oncology.
[38] A. Ivascu,et al. Diversity of cell-mediated adhesions in breast cancer spheroids. , 2007, International journal of oncology.
[39] R. Kerbel,et al. Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro. , 2004, Molecular cancer therapeutics.
[40] K. Neoh,et al. Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. , 2009, Journal of materials science. Materials in medicine.
[41] James P. Freyer,et al. The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.